Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients

Journal of Clinical Virology

Volumn 22, Issue 1, 2001, Pages 111-116

  Piiparinen, H ^a   Hockerstedt K ^a   Gronhagen Riska C ^a   Lappalainen, M ^a   Suni, J ^a   Lautenschlager, I ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

CMV; Diagnosis; Quantitative PCR; Transplant patients

Indexed keywords

ANTIGEN; ANTIVIRUS AGENT; GANCICLOVIR;

ADULT; ARTICLE; BIOASSAY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LEUKOCYTE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GANCICLOVIR; IMMUNOENZYME TECHNIQUES; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; OPPORTUNISTIC INFECTIONS; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRAL MATRIX PROTEINS;

EID: 0034980289     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(01)00173-1     Document Type: Article

References (22)

1. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation
2. Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation
3. Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus-infected subjects
4. Comparison of quantitative cytomegalovirus CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients
5. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
6. Clinical utility of a quantitative polymerase chain reaction for diagnosis of cytomegalovirus disease in solid organ transplant patients
7. Comparative quantification of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients
8. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes
9. Evaluation of the AMLICOR CMV test for direct detection of cytomegalovirus in plasma specimens
10. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients
11. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation
12. Cytomegalovirus hepatitis in liver transplantation: Prospective analysis of 93 consecutive orthotopic liver transplantations
13. Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-protein patients
14. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and asses response to ganciclovir therapy in renal transplant recipients
15. Infection in organ-transplant recipients
16. Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation
17. Detection of cytomegalovirus DNA in human specimens by LightCycler PCR
18. Cytomegalovirus-antigenemia as a useful marker of symptomatic cytomegalovirus disease after renal transplantation: a report of 130 consecutive patients
19. The cytomegalovirus antigenemia assay: a plea for standardization
20. Cytomegalovirus antigenemia
21. Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction
22. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients